Stephanie Diez de Sollano: Recognition and Management of Ehlers-Danlos Syndrome
Stephanie Diez de Sollano, Health Care Professional at Stanford Health Care, shared a post on LinkedIn.
Ehlers-Danlos Syndrome (EDS) is a group of rare, inherited connective tissue disorders that affect the body’s ability to produce collagen, leading to hypermobility, skin fragility, and a range of debilitating symptoms.
This condition, often undiagnosed or misdiagnosed, significantly impacts the lives of those affected.
Individuals with EDS experience joint hypermobility, chronic pain, skin that bruises easily, fatigue, and in severe cases, life-threatening complications.
The spectrum of EDS subtypes includes classical, hypermobile, vascular, and others, each with distinct features and severity.
The challenges of EDS extend beyond the physical.
Mental health struggles, including anxiety and depression, often accompany the chronic pain and uncertainty of the condition.
The lack of awareness and understanding in society further complicates the daily lives of those with EDS, as the condition is often misunderstood or overlooked.”
Stay updated with Hemostasis Today.
-
Aug 31, 2026, 05:35Does LDL Cholesterol Influence VTE Risk? – Ordo Fraterna Fibonacci
-
Aug 31, 2026, 05:19Tania Ahuja: Apixaban in Abdominal Transplant Patients
-
Aug 31, 2026, 04:28Reza Hafidz IrawanÖ‰ Automated Antibody Titration With Erytra Eflexis
-
Aug 31, 2026, 04:17Safa Chenganath: Stenosis vs Thrombosis – Hemodialysis Vascular Access
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session